In this issue:
Conventional agents in paediatric psoriasis
Korean psoriasis epidemiology and cardiovascular comorbidities
Nail involvement as prognostic factor in biological therapy
Biosimilar ABP 501 vs adalimumab for plaque psoriasis
Biosimilar GP2015 vs etanercept for plaque psoriasis
Risk of suicidality in psoriasis patients
Calcipotriol + betamethasone dipropionate aerosol foam vs gel
Comparison of psoriatic patients with and without psoriatic arthritis
Interleukin-17 antagonists in plaque psoriasis
Continuous vs interrupted therapy with ixekizumab
Age group disparities in psoriasis
Please login below to download this issue (PDF)